Jacobson P B, Schrier D J
Department of Immunopathology, Parke-Davis Pharmaceutical Research/Division, Warner Lambert Company, Ann Arbor, MI 48105.
J Immunol. 1993 Nov 15;151(10):5639-52.
Recent evidence suggests that phospholipase A2 (PLA2)-derived lipid mediators may regulate a number of neutrophil responses including degranulation and adhesion. In view of the potential role of PLA2 in stimulus-secretion coupling, we examined the relationship between PLA2 activation and the surface expression of CD11b/CD18 (MAC-1) in human polymorphonuclear leukocytes (hPMNL), including the functional consequences of PLA2 inactivation on MAC-1-dependent adhesion. The selective inhibition of PLA2 by the marine natural products manoalide (MLD) and scalaradial (SLD) blocks [3H]arachidonic acid (AA) release in calcium ionophore A23187-stimulated neutrophils, and also inhibits secretion of specific and azurophilic granule constituents. Additional studies demonstrate that MLD, SLD, and other less potent PLA2 inhibitors such as 4-bromophenacylbromide and nordihydroguiaretic acid inhibit the surface expression of MAC-1 (IC50: MLD, 0.33 microM; SLD, 0.23 microM; 4-bromophenacylbromide, 2.8 microM; NDGA, 3.5 microM) at concentrations similar to those at which they inhibit [3H]AA release. Inhibitors of cyclooxygenase, 5-lipoxygenase, protein kinase C, or calcium channel antagonists have no effect on MAC-1 expression. PLA2 inactivation also prevents MAC-1 up-regulation in hPMNL stimulated with FMLP, IL-8, TNF-alpha, PMA, or platelet activating factor. In FMLP-stimulated hPMNL, under conditions in which no secondary granule constituents are secreted, MAC-1 and alkaline phosphatase up-regulation from intracellular granules is inhibited by MLD and SLD. Functional assays also demonstrate that MLD and SLD block MAC-1-dependent adhesion of activated neutrophils to keyhole limpet hemocyanin at concentrations that block the surface expression of MAC-1. [3H]AA release and MAC-1 expression in MLD and SLD-treated hPMNL could be recovered in the presence of 1 mM hydroxylamine in a time-dependent fashion, consistent with reported data that MLD and SLD inactivate PLA2 through Schiff base formation. In summary, these data emphasize the role of PLA2 as a key regulator of MAC-1 expression in models of neutrophil adhesion.
近期证据表明,磷脂酶A2(PLA2)衍生的脂质介质可能调节包括脱颗粒和黏附在内的多种中性粒细胞反应。鉴于PLA2在刺激-分泌偶联中的潜在作用,我们研究了PLA2激活与人多形核白细胞(hPMNL)中CD11b/CD18(MAC-1)表面表达之间的关系,包括PLA2失活对MAC-1依赖性黏附的功能影响。海洋天然产物 manoalide(MLD)和 scalaradial(SLD)对PLA2的选择性抑制可阻断钙离子载体A23187刺激的中性粒细胞中[3H]花生四烯酸(AA)的释放,还可抑制特异性和嗜天青颗粒成分的分泌。进一步研究表明,MLD、SLD以及其他效力较弱的PLA2抑制剂,如4-溴苯甲酰溴和去甲二氢愈创木酸,在抑制[3H]AA释放的浓度下,可抑制MAC-1的表面表达(IC50:MLD为0.33 microM;SLD为0.23 microM;4-溴苯甲酰溴为2.8 microM;NDGA为3.5 microM)。环氧化酶、5-脂氧合酶、蛋白激酶C抑制剂或钙通道拮抗剂对MAC-1表达无影响。PLA2失活还可阻止FMLP、IL-8、TNF-α、PMA或血小板活化因子刺激的hPMNL中MAC-1的上调。在FMLP刺激的hPMNL中,在无次级颗粒成分分泌的条件下,MLD和SLD可抑制细胞内颗粒中MAC-1和碱性磷酸酶的上调。功能分析还表明,MLD和SLD在阻断MAC-1表面表达的浓度下,可阻断活化中性粒细胞对钥孔戚血蓝蛋白的MAC-1依赖性黏附。在1 mM羟胺存在下,MLD和SLD处理的hPMNL中[3H]AA释放和MAC-1表达可随时间恢复,这与报道的数据一致,即MLD和SLD通过席夫碱形成使PLA2失活。总之,这些数据强调了PLA2在中性粒细胞黏附模型中作为MAC-1表达关键调节因子的作用。